New predictive window to Kidney Health
The Serenno system is a pioneering Urine Output (UO) Monitor
for hospitalized patients improving
Acute Kidney Injury (AKI) prediction
and fluid management.
The problem
Acute Kidney Injury (AKI) - an avoidable, dangerous and common complication that affects 19 million patients worldwide every year.Â
AKI is hard to treat and reverse once it manifests fully.
The Solution
Continuous UO measurement - the only reliable way to detect, assess, possibly anticipate AKI occurrence.
Earlier AKI detection – reduces patient risk and renders most cases preventable.
The Serenno system advantages:
Fully automatic, low workload, hands free
EMR Connected, delivering more actionable data
Safe, robust and reliable for every patient
Low cost, easy to use, streamline into the ICU
Unique use options
ER>OR>ICU mobility
Quarantine
ICU
Telehealth/
Remote ICU
Home
ICU
Kidney failure is among the most common and dangerous ICU complications. Typically, kidney injury is detected relatively late, often after it is impossible to prevent further progression... The Serenno system will promote early detection of kidney injury, presumably while there is still time to intervene and prevent further damage.
Daniel I. Sessler, MD
Cleveland Clinic, Serenno Medical Advisor
Team
The Serenno team combines over 70 years of experience in all aspects of the medical device business.
Tomer Lark
CEO, Founder
Noam Hadas
CTO, Founder
Sagie Meshulam
VP R&D
Anna Levin
VP Clinical/Regulatory
